ARZNEIMITTELABGABEVORRICHTUNG

Patent europeic · EP4234694 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4234694
Numer da la dumonda
EP23171500
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
20-11-2013
Publitgà
30-08-2023
Concedì
01-04-2026
La protecziun finescha il pli tard
19-11-2033
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61M 5/32 (2006.01)
A61M 5/20 (2006.01)
A61M 5/42 (2006.01)
A61M 5/14 (2006.01)
A61M 5/30 (2006.01)
A61M 5/158 (2006.01)
A61M 5/31 (2006.01)
A61M 25/02 (2006.01)
A61M 25/00 (2006.01)
A61M 25/06 (2006.01)
A61M 5/142 (2006.01)
C07K 16/40 (2006.01)
A61K 38/00 (2006.01)
C12N 9/64 (2006.01)
Prioritad
US 201261729303 P 21.11.2012
US 201361774567 P 07.03.2013
Derivà da
EP19219003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-04-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.04.2026

Partidas

Possessur

Amgen Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US

Inventur

MEHTA, Dhairya

San Francisco, CA 94080, US

TOY, Stephanie

Moorpark, CA 93021, US

RING, Lawrence

Valencia, CA 91355, US

TAMTORO, Ferry

Newbury Park, CA 91320, US

CAIRNS, Alexander Stuart

Santa Monica, CA 90404, US

GIBSON, Scott Robert

Grenada Hills, CA 91344, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.